

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.65203271 |
| 2 | central nervous system myelination (GO:0022010) | 5.65203271 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.37619115 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.37619115 |
| 5 | fatty acid elongation (GO:0030497) | 5.29431188 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.82632024 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.82632024 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.70443496 |
| 9 | detection of molecule of bacterial origin (GO:0032490) | 4.52851454 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.39071826 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39071826 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.33166670 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.33166670 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.33166670 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.33166670 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.33166670 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.33166670 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 4.21892832 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.17959043 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.13452918 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 3.96710896 |
| 22 | bile acid biosynthetic process (GO:0006699) | 3.76061936 |
| 23 | cellular extravasation (GO:0045123) | 3.71347954 |
| 24 | very long-chain fatty acid metabolic process (GO:0000038) | 3.70135245 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.66530599 |
| 26 | detection of other organism (GO:0098543) | 3.65690825 |
| 27 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.65387973 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.63297160 |
| 29 | protein carboxylation (GO:0018214) | 3.63297160 |
| 30 | cholesterol biosynthetic process (GO:0006695) | 3.59122484 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 3.58512644 |
| 32 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.58475197 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.58099589 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.56706633 |
| 35 | plasma lipoprotein particle clearance (GO:0034381) | 3.56228796 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.55388150 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.55074726 |
| 38 | microglial cell activation (GO:0001774) | 3.53611456 |
| 39 | tyrosine metabolic process (GO:0006570) | 3.51680249 |
| 40 | myelination (GO:0042552) | 3.50380761 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.50214713 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.50175992 |
| 43 | axon ensheathment (GO:0008366) | 3.49505059 |
| 44 | ensheathment of neurons (GO:0007272) | 3.49505059 |
| 45 | import into cell (GO:0098657) | 3.46712111 |
| 46 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.45718296 |
| 47 | coenzyme catabolic process (GO:0009109) | 3.44839286 |
| 48 | heme transport (GO:0015886) | 3.43947960 |
| 49 | cysteine metabolic process (GO:0006534) | 3.42463049 |
| 50 | response to peptidoglycan (GO:0032494) | 3.42047448 |
| 51 | response to methylmercury (GO:0051597) | 3.39408850 |
| 52 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.34472730 |
| 53 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.33643919 |
| 54 | sulfur amino acid catabolic process (GO:0000098) | 3.32128084 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29640837 |
| 56 | macrophage activation (GO:0042116) | 3.26834275 |
| 57 | detection of biotic stimulus (GO:0009595) | 3.25369464 |
| 58 | bile acid metabolic process (GO:0008206) | 3.23149344 |
| 59 | regulation of fibrinolysis (GO:0051917) | 3.20902683 |
| 60 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.20641434 |
| 61 | sterol biosynthetic process (GO:0016126) | 3.19866453 |
| 62 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.16788741 |
| 63 | tryptophan catabolic process (GO:0006569) | 3.16685126 |
| 64 | indole-containing compound catabolic process (GO:0042436) | 3.16685126 |
| 65 | indolalkylamine catabolic process (GO:0046218) | 3.16685126 |
| 66 | detection of bacterium (GO:0016045) | 3.16067476 |
| 67 | high-density lipoprotein particle remodeling (GO:0034375) | 3.13900362 |
| 68 | negative regulation of interleukin-12 production (GO:0032695) | 3.12771432 |
| 69 | regulation of protein activation cascade (GO:2000257) | 3.12368181 |
| 70 | thioester biosynthetic process (GO:0035384) | 3.11916572 |
| 71 | acyl-CoA biosynthetic process (GO:0071616) | 3.11916572 |
| 72 | complement activation, alternative pathway (GO:0006957) | 3.10882118 |
| 73 | response to lipoprotein particle (GO:0055094) | 3.10583241 |
| 74 | cholesterol efflux (GO:0033344) | 3.08330186 |
| 75 | short-chain fatty acid metabolic process (GO:0046459) | 3.06932441 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06600518 |
| 77 | response to host immune response (GO:0052572) | 3.06600518 |
| 78 | tryptophan metabolic process (GO:0006568) | 3.05371913 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03964196 |
| 80 | L-amino acid import (GO:0043092) | 3.02298236 |
| 81 | urea metabolic process (GO:0019627) | 3.01861297 |
| 82 | urea cycle (GO:0000050) | 3.01861297 |
| 83 | aromatic amino acid family metabolic process (GO:0009072) | 3.00897850 |
| 84 | response to muramyl dipeptide (GO:0032495) | 2.99253120 |
| 85 | regulation of triglyceride catabolic process (GO:0010896) | 2.98628727 |
| 86 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.98467512 |
| 87 | reverse cholesterol transport (GO:0043691) | 2.98100857 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.98081709 |
| 89 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.96890236 |
| 90 | kynurenine metabolic process (GO:0070189) | 2.96704260 |
| 91 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.95968203 |
| 92 | cellular glucuronidation (GO:0052695) | 2.95749411 |
| 93 | regulation of macrophage cytokine production (GO:0010935) | 2.95720719 |
| 94 | ethanol oxidation (GO:0006069) | 2.95320968 |
| 95 | homocysteine metabolic process (GO:0050667) | 2.94930047 |
| 96 | regulation of complement activation (GO:0030449) | 2.94128270 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93557632 |
| 98 | response to host (GO:0075136) | 2.93557632 |
| 99 | response to host defenses (GO:0052200) | 2.93557632 |
| 100 | positive regulation of macrophage cytokine production (GO:0060907) | 2.93245221 |
| 101 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.92573160 |
| 102 | negative regulation of lipase activity (GO:0060192) | 2.91586519 |
| 103 | fibrinolysis (GO:0042730) | 2.91284465 |
| 104 | regulation of cholesterol esterification (GO:0010872) | 2.90775905 |
| 105 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.89280582 |
| 106 | acetyl-CoA metabolic process (GO:0006084) | 2.89276666 |
| 107 | regulation of lipoprotein metabolic process (GO:0050746) | 2.85289961 |
| 108 | B cell receptor signaling pathway (GO:0050853) | 2.84203766 |
| 109 | cofactor catabolic process (GO:0051187) | 2.83850569 |
| 110 | regulation of cholesterol metabolic process (GO:0090181) | 2.83604855 |
| 111 | cholesterol metabolic process (GO:0008203) | 2.80723750 |
| 112 | positive regulation of Rap GTPase activity (GO:0032854) | 2.80245550 |
| 113 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77404396 |
| 114 | positive regulation of mast cell activation (GO:0033005) | 2.76293509 |
| 115 | protein-lipid complex remodeling (GO:0034368) | 2.75360017 |
| 116 | macromolecular complex remodeling (GO:0034367) | 2.75360017 |
| 117 | plasma lipoprotein particle remodeling (GO:0034369) | 2.75360017 |
| 118 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.75245327 |
| 119 | cholesterol homeostasis (GO:0042632) | 2.75069070 |
| 120 | amyloid precursor protein metabolic process (GO:0042982) | 2.74950557 |
| 121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.74544220 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.74544220 |
| 123 | acylglycerol homeostasis (GO:0055090) | 2.72579402 |
| 124 | triglyceride homeostasis (GO:0070328) | 2.72579402 |
| 125 | myelin maintenance (GO:0043217) | 2.71590598 |
| 126 | sterol homeostasis (GO:0055092) | 2.71220578 |
| 127 | creatine metabolic process (GO:0006600) | 2.71060984 |
| 128 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.70723231 |
| 129 | cellular ketone body metabolic process (GO:0046950) | 2.70414291 |
| 130 | nitrogen cycle metabolic process (GO:0071941) | 2.69693373 |
| 131 | acyl-CoA metabolic process (GO:0006637) | 2.69434596 |
| 132 | thioester metabolic process (GO:0035383) | 2.69434596 |
| 133 | protein-lipid complex assembly (GO:0065005) | 2.69388664 |
| 134 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67582439 |
| 135 | cellular biogenic amine catabolic process (GO:0042402) | 2.67400090 |
| 136 | amine catabolic process (GO:0009310) | 2.67400090 |
| 137 | uronic acid metabolic process (GO:0006063) | 2.67337558 |
| 138 | glucuronate metabolic process (GO:0019585) | 2.67337558 |
| 139 | myeloid cell activation involved in immune response (GO:0002275) | 2.66433651 |
| 140 | cellular modified amino acid catabolic process (GO:0042219) | 2.65735261 |
| 141 | alpha-amino acid catabolic process (GO:1901606) | 2.65133078 |
| 142 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.64535189 |
| 143 | sterol metabolic process (GO:0016125) | 2.63763726 |
| 144 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63551086 |
| 145 | positive thymic T cell selection (GO:0045059) | 2.63179542 |
| 146 | iron coordination entity transport (GO:1901678) | 2.61978578 |
| 147 | phospholipid homeostasis (GO:0055091) | 2.61780178 |
| 148 | phospholipid efflux (GO:0033700) | 2.61672510 |
| 149 | regulation of plasminogen activation (GO:0010755) | 2.61441663 |
| 150 | cellular response to cholesterol (GO:0071397) | 2.61365782 |
| 151 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.61313886 |
| 152 | response to mercury ion (GO:0046689) | 2.61278620 |
| 153 | cellular response to epinephrine stimulus (GO:0071872) | 2.60724224 |
| 154 | regulation of beta-amyloid formation (GO:1902003) | 2.60101364 |
| 155 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.59077583 |
| 156 | negative regulation of T cell mediated immunity (GO:0002710) | 2.59044987 |
| 157 | neutrophil activation (GO:0042119) | 2.58648190 |
| 158 | regulation of leukocyte degranulation (GO:0043300) | 2.54382330 |
| 159 | regulation of mast cell degranulation (GO:0043304) | 2.53248715 |
| 160 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.51864267 |
| 161 | germinal center formation (GO:0002467) | 2.48148250 |
| 162 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.46405248 |
| 163 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.46405248 |
| 164 | regulation of ARF protein signal transduction (GO:0032012) | 2.45941045 |
| 165 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.43893816 |
| 166 | neutrophil mediated immunity (GO:0002446) | 2.43223354 |
| 167 | regulation of necroptotic process (GO:0060544) | 2.42150970 |
| 168 | response to interleukin-15 (GO:0070672) | 2.42011860 |
| 169 | leukocyte aggregation (GO:0070486) | 2.41992797 |
| 170 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.40804545 |
| 171 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.39635983 |
| 172 | positive regulation of mast cell degranulation (GO:0043306) | 2.39635983 |
| 173 | activated T cell proliferation (GO:0050798) | 2.39251066 |
| 174 | regulation of platelet aggregation (GO:0090330) | 2.38868043 |
| 175 | regulation of Rap GTPase activity (GO:0032317) | 2.38653800 |
| 176 | positive T cell selection (GO:0043368) | 2.37709423 |
| 177 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.36528289 |
| 178 | cellular response to ethanol (GO:0071361) | 2.36214201 |
| 179 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.35803069 |
| 180 | granulocyte activation (GO:0036230) | 2.35104349 |
| 181 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.34531551 |
| 182 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.30874141 |
| 183 | hypotonic response (GO:0006971) | 2.30795078 |
| 184 | regulation of mast cell activation (GO:0033003) | 2.28658726 |
| 185 | regulation of cellular amide metabolic process (GO:0034248) | 2.27000620 |
| 186 | negative regulation of type 2 immune response (GO:0002829) | 2.26828831 |
| 187 | negative thymic T cell selection (GO:0045060) | 2.26517484 |
| 188 | regulation of regulated secretory pathway (GO:1903305) | 2.24702115 |
| 189 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.23575690 |
| 190 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.23226748 |
| 191 | regulation of tolerance induction (GO:0002643) | 2.21003532 |
| 192 | negative T cell selection (GO:0043383) | 2.19187159 |
| 193 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.18911292 |
| 194 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.18907686 |
| 195 | positive regulation of receptor recycling (GO:0001921) | 2.18718718 |
| 196 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.18614121 |
| 197 | T-helper 1 type immune response (GO:0042088) | 2.18367022 |
| 198 | positive regulation of B cell differentiation (GO:0045579) | 2.17821603 |
| 199 | negative regulation of interleukin-17 production (GO:0032700) | 2.17801793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.17514173 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.98561084 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.70164167 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.31426355 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.23415009 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.10590250 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.09232704 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.90424245 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.62010553 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42180904 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.38867760 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33316656 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.31044546 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.23306518 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20803873 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.15797664 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01691124 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97875418 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97292607 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.96842249 |
| 21 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.94272379 |
| 22 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.94272379 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.87868128 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85988736 |
| 25 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85295933 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81765340 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.78971796 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78686371 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77105343 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.76800525 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73991949 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.73257888 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.73252180 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73218479 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67907445 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66638185 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.65948492 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.65495457 |
| 39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.63388288 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56479838 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54387677 |
| 42 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.53555600 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51068763 |
| 44 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48331744 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46129883 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44888947 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44746762 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44239639 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42528024 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.39729658 |
| 51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.36834383 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35573080 |
| 53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34616808 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34404125 |
| 55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.34380614 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33854241 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33539694 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.32808212 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32295548 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29164899 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.28176754 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27552527 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25093570 |
| 64 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.24961527 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24378547 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24180007 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23278714 |
| 68 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22470060 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21699371 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21175753 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20416688 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18497044 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18449655 |
| 74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18372992 |
| 75 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.18111546 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17845695 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17647804 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.16462624 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16254985 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16138547 |
| 81 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15952857 |
| 82 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15381318 |
| 83 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15323858 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14521824 |
| 85 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.11245504 |
| 86 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11083907 |
| 87 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10845805 |
| 88 | MYB_26560356_Chip-Seq_TH2_Human | 1.10319302 |
| 89 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10016443 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10004739 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09389778 |
| 92 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09191232 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07104041 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06146562 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05310335 |
| 96 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.05299378 |
| 97 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.05094323 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04900719 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04043015 |
| 100 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03950017 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03660183 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03633967 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03568887 |
| 104 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03509420 |
| 105 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03106183 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02469103 |
| 107 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01636101 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00908716 |
| 109 | MAF_26560356_Chip-Seq_TH1_Human | 1.00210951 |
| 110 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00131461 |
| 111 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97701244 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97447634 |
| 113 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96856434 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96329441 |
| 115 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95518463 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95338064 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.94973735 |
| 118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93546610 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93279865 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93142593 |
| 121 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.92976148 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92882632 |
| 123 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92092758 |
| 124 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91916432 |
| 125 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91499340 |
| 126 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.91083843 |
| 127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90871111 |
| 128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90812501 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90243872 |
| 130 | MYB_26560356_Chip-Seq_TH1_Human | 0.88455673 |
| 131 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88414742 |
| 132 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.88306614 |
| 133 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87846866 |
| 134 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87447737 |
| 135 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86221981 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85405571 |
| 137 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84812754 |
| 138 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84355422 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84293029 |
| 140 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84233863 |
| 141 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83427677 |
| 142 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83152739 |
| 143 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83152739 |
| 144 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82701055 |
| 145 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82604661 |
| 146 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82004953 |
| 147 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.80304049 |
| 148 | UTX_26944678_Chip-Seq_JUKART_Human | 0.80215808 |
| 149 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79981862 |
| 150 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79193916 |
| 151 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.78994814 |
| 152 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78653333 |
| 153 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78361248 |
| 154 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78126008 |
| 155 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77776222 |
| 156 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.77444845 |
| 157 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76779129 |
| 158 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.76627391 |
| 159 | CBP_21632823_ChIP-Seq_H3396_Human | 0.75821259 |
| 160 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75797768 |
| 161 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.75136813 |
| 162 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.74641738 |
| 163 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73270001 |
| 164 | STAT3_23295773_ChIP-Seq_U87_Human | 0.72753495 |
| 165 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72564766 |
| 166 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72451265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.00691255 |
| 2 | MP0005360_urolithiasis | 4.80724664 |
| 3 | MP0003724_increased_susceptibility_to | 4.30573236 |
| 4 | MP0005365_abnormal_bile_salt | 3.67316338 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.66988156 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.43391584 |
| 7 | MP0003303_peritoneal_inflammation | 3.43138028 |
| 8 | MP0009840_abnormal_foam_cell | 3.26565429 |
| 9 | MP0003690_abnormal_glial_cell | 3.18676232 |
| 10 | MP0000920_abnormal_myelination | 3.10098269 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 3.03882216 |
| 12 | MP0003436_decreased_susceptibility_to | 2.82505236 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.81159523 |
| 14 | MP0003252_abnormal_bile_duct | 2.72416318 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.57475009 |
| 16 | MP0003828_pulmonary_edema | 2.56993790 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.37541062 |
| 18 | MP0002419_abnormal_innate_immunity | 2.37220896 |
| 19 | MP0003195_calcinosis | 2.21958778 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.10889611 |
| 21 | MP0005332_abnormal_amino_acid | 2.07069838 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.05697504 |
| 23 | MP0005083_abnormal_biliary_tract | 2.02923394 |
| 24 | MP0008260_abnormal_autophagy | 2.02462513 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.97878747 |
| 26 | MP0003950_abnormal_plasma_membrane | 1.97588438 |
| 27 | MP0001800_abnormal_humoral_immune | 1.96874202 |
| 28 | MP0005025_abnormal_response_to | 1.96760909 |
| 29 | MP0005000_abnormal_immune_tolerance | 1.93850240 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.91426265 |
| 31 | MP0010678_abnormal_skin_adnexa | 1.81587573 |
| 32 | MP0000685_abnormal_immune_system | 1.81189537 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.76670369 |
| 34 | MP0005387_immune_system_phenotype | 1.75985267 |
| 35 | MP0001790_abnormal_immune_system | 1.75985267 |
| 36 | MP0005171_absent_coat_pigmentation | 1.75914829 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.74819999 |
| 38 | MP0002723_abnormal_immune_serum | 1.74720642 |
| 39 | MP0009785_altered_susceptibility_to | 1.73962937 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.73049285 |
| 41 | MP0000383_abnormal_hair_follicle | 1.71500973 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.71387380 |
| 43 | MP0005671_abnormal_response_to | 1.66303686 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.65861639 |
| 45 | MP0005670_abnormal_white_adipose | 1.65709415 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.64762193 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.63331591 |
| 48 | MP0003136_yellow_coat_color | 1.62687371 |
| 49 | MP0001819_abnormal_immune_cell | 1.60270059 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.57073067 |
| 51 | MP0004510_myositis | 1.52556081 |
| 52 | MP0001661_extended_life_span | 1.50641086 |
| 53 | MP0004381_abnormal_hair_follicle | 1.50399585 |
| 54 | MP0000604_amyloidosis | 1.48925688 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.46927468 |
| 56 | MP0005408_hypopigmentation | 1.46076789 |
| 57 | MP0000647_abnormal_sebaceous_gland | 1.45965182 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.42557566 |
| 59 | MP0003329_amyloid_beta_deposits | 1.42310725 |
| 60 | MP0005275_abnormal_skin_tensile | 1.40767131 |
| 61 | MP0004947_skin_inflammation | 1.38845691 |
| 62 | MP0003763_abnormal_thymus_physiology | 1.35253336 |
| 63 | MP0003634_abnormal_glial_cell | 1.34569763 |
| 64 | MP0000609_abnormal_liver_physiology | 1.34553956 |
| 65 | MP0004883_abnormal_blood_vessel | 1.32978538 |
| 66 | MP0005166_decreased_susceptibility_to | 1.32454702 |
| 67 | MP0004134_abnormal_chest_morphology | 1.32200465 |
| 68 | MP0002405_respiratory_system_inflammati | 1.30744747 |
| 69 | MP0004272_abnormal_basement_membrane | 1.29770294 |
| 70 | MP0005409_darkened_coat_color | 1.29723734 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 1.29259667 |
| 72 | MP0009115_abnormal_fat_cell | 1.28872934 |
| 73 | MP0003300_gastrointestinal_ulcer | 1.28753182 |
| 74 | MP0006082_CNS_inflammation | 1.26010252 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.25668151 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.25433364 |
| 77 | MP0003868_abnormal_feces_composition | 1.24603739 |
| 78 | MP0004484_altered_response_of | 1.24205004 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 1.23762480 |
| 80 | MP0009278_abnormal_bone_marrow | 1.23034742 |
| 81 | MP0003045_fibrosis | 1.21929926 |
| 82 | MP0008004_abnormal_stomach_pH | 1.20302224 |
| 83 | MP0005451_abnormal_body_composition | 1.18931397 |
| 84 | MP0000716_abnormal_immune_system | 1.17834128 |
| 85 | MP0005623_abnormal_meninges_morphology | 1.16721888 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.14909599 |
| 87 | MP0001545_abnormal_hematopoietic_system | 1.14554507 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 1.14554507 |
| 89 | MP0002398_abnormal_bone_marrow | 1.13852462 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13812580 |
| 91 | MP0004742_abnormal_vestibular_system | 1.12601469 |
| 92 | MP0004885_abnormal_endolymph | 1.11528454 |
| 93 | MP0003011_delayed_dark_adaptation | 1.09422184 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 1.09361538 |
| 95 | MP0000343_altered_response_to | 1.08998921 |
| 96 | MP0003866_abnormal_defecation | 1.07800509 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 1.06190651 |
| 98 | MP0005666_abnormal_adipose_tissue | 1.05803007 |
| 99 | MP0000015_abnormal_ear_pigmentation | 1.05664137 |
| 100 | MP0001299_abnormal_eye_distance/ | 1.04896178 |
| 101 | MP0002332_abnormal_exercise_endurance | 1.04363817 |
| 102 | MP0001542_abnormal_bone_strength | 1.03346856 |
| 103 | MP0003646_muscle_fatigue | 1.02224212 |
| 104 | MP0003632_abnormal_nervous_system | 1.02055512 |
| 105 | MP0003879_abnormal_hair_cell | 1.00348446 |
| 106 | MP0003633_abnormal_nervous_system | 0.99514217 |
| 107 | MP0001958_emphysema | 0.99296208 |
| 108 | MP0004036_abnormal_muscle_relaxation | 0.98399239 |
| 109 | MP0002168_other_aberrant_phenotype | 0.98361040 |
| 110 | MP0000462_abnormal_digestive_system | 0.97361008 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.96506451 |
| 112 | MP0000579_abnormal_nail_morphology | 0.94949694 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.93965331 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.93713852 |
| 115 | MP0002090_abnormal_vision | 0.93580443 |
| 116 | MP0002132_abnormal_respiratory_system | 0.93386433 |
| 117 | MP0005388_respiratory_system_phenotype | 0.93011828 |
| 118 | MP0002133_abnormal_respiratory_system | 0.93011828 |
| 119 | MP0005535_abnormal_body_temperature | 0.91185773 |
| 120 | MP0008469_abnormal_protein_level | 0.90933975 |
| 121 | MP0000249_abnormal_blood_vessel | 0.90791677 |
| 122 | MP0002060_abnormal_skin_morphology | 0.89464724 |
| 123 | MP0000427_abnormal_hair_cycle | 0.89436057 |
| 124 | MP0000689_abnormal_spleen_morphology | 0.88734597 |
| 125 | MP0002396_abnormal_hematopoietic_system | 0.88278431 |
| 126 | MP0001243_abnormal_dermal_layer | 0.87165953 |
| 127 | MP0010368_abnormal_lymphatic_system | 0.86734345 |
| 128 | MP0008569_lethality_at_weaning | 0.82803114 |
| 129 | MP0009697_abnormal_copulation | 0.82452626 |
| 130 | MP0003656_abnormal_erythrocyte_physiolo | 0.82444894 |
| 131 | MP0002722_abnormal_immune_system | 0.82425844 |
| 132 | MP0002429_abnormal_blood_cell | 0.81437509 |
| 133 | MP0008874_decreased_physiological_sensi | 0.80716964 |
| 134 | MP0000733_abnormal_muscle_development | 0.80492462 |
| 135 | MP0003631_nervous_system_phenotype | 0.80181505 |
| 136 | MP0003453_abnormal_keratinocyte_physiol | 0.79820129 |
| 137 | MP0005174_abnormal_tail_pigmentation | 0.79283750 |
| 138 | MP0001851_eye_inflammation | 0.79238589 |
| 139 | MP0002896_abnormal_bone_mineralization | 0.78415240 |
| 140 | MP0005375_adipose_tissue_phenotype | 0.78147023 |
| 141 | MP0003075_altered_response_to | 0.78036185 |
| 142 | MP0000747_muscle_weakness | 0.77319847 |
| 143 | MP0005167_abnormal_blood-brain_barrier | 0.74160029 |
| 144 | MP0003172_abnormal_lysosome_physiology | 0.73750941 |
| 145 | MP0002971_abnormal_brown_adipose | 0.71941237 |
| 146 | MP0004859_abnormal_synaptic_plasticity | 0.71872637 |
| 147 | MP0000566_synostosis | 0.71588398 |
| 148 | MP0001853_heart_inflammation | 0.71364401 |
| 149 | MP0000377_abnormal_hair_follicle | 0.71308289 |
| 150 | MP0001346_abnormal_lacrimal_gland | 0.71096602 |
| 151 | MP0000858_altered_metastatic_potential | 0.70699047 |
| 152 | MP0003448_altered_tumor_morphology | 0.70604992 |
| 153 | MP0002166_altered_tumor_susceptibility | 0.70194343 |
| 154 | MP0001324_abnormal_eye_pigmentation | 0.69567225 |
| 155 | MP0001177_atelectasis | 0.68760763 |
| 156 | MP0002933_joint_inflammation | 0.68741132 |
| 157 | MP0009763_increased_sensitivity_to | 0.68721394 |
| 158 | MP0002098_abnormal_vibrissa_morphology | 0.67624205 |
| 159 | MP0005395_other_phenotype | 0.67416167 |
| 160 | MP0009764_decreased_sensitivity_to | 0.67187887 |
| 161 | MP0005595_abnormal_vascular_smooth | 0.65533538 |
| 162 | MP0003091_abnormal_cell_migration | 0.65209078 |
| 163 | MP0003566_abnormal_cell_adhesion | 0.64673743 |
| 164 | MP0005164_abnormal_response_to | 0.64633396 |
| 165 | MP0005503_abnormal_tendon_morphology | 0.64476636 |
| 166 | MP0000598_abnormal_liver_morphology | 0.63390246 |
| 167 | MP0004130_abnormal_muscle_cell | 0.60829608 |
| 168 | MP0005023_abnormal_wound_healing | 0.60799371 |
| 169 | MP0005508_abnormal_skeleton_morphology | 0.60537788 |
| 170 | MP0003279_aneurysm | 0.60051604 |
| 171 | MP0003937_abnormal_limbs/digits/tail_de | 0.59409773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.17790228 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.13723613 |
| 3 | Xanthomatosis (HP:0000991) | 5.09168145 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.66277156 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.49654225 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.44749616 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.01719998 |
| 8 | Spontaneous hematomas (HP:0007420) | 3.98432997 |
| 9 | Neurofibrillary tangles (HP:0002185) | 3.91427174 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.85179897 |
| 11 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.74156729 |
| 12 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.74156729 |
| 13 | Myositis (HP:0100614) | 3.72770553 |
| 14 | Orchitis (HP:0100796) | 3.68770093 |
| 15 | Complement deficiency (HP:0004431) | 3.60715500 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.60597249 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.50082022 |
| 18 | Optic neuritis (HP:0100653) | 3.50082022 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 3.46442591 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.44556854 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.43306458 |
| 22 | Premature rupture of membranes (HP:0001788) | 3.38756804 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.34144295 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.25387478 |
| 25 | Epidermoid cyst (HP:0200040) | 3.24118083 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.16977812 |
| 27 | Hypolipoproteinemia (HP:0010981) | 3.11921931 |
| 28 | Prolonged bleeding time (HP:0003010) | 3.05968251 |
| 29 | Myocardial infarction (HP:0001658) | 3.03829198 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.00665280 |
| 31 | Gingival bleeding (HP:0000225) | 2.92735879 |
| 32 | Difficulty running (HP:0009046) | 2.90626631 |
| 33 | Fat malabsorption (HP:0002630) | 2.89870200 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 2.86067981 |
| 35 | Papilledema (HP:0001085) | 2.84235712 |
| 36 | Gingivitis (HP:0000230) | 2.83359477 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.81792126 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.81384410 |
| 39 | Abnormality of the corticospinal tract (HP:0002492) | 2.79766737 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77845245 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 2.77845245 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.71551438 |
| 43 | Joint hemorrhage (HP:0005261) | 2.70470092 |
| 44 | Abnormality of complement system (HP:0005339) | 2.68703445 |
| 45 | Muscle fiber splitting (HP:0003555) | 2.68468626 |
| 46 | Vascular calcification (HP:0004934) | 2.66729386 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.65835545 |
| 48 | Recurrent skin infections (HP:0001581) | 2.64901713 |
| 49 | Parakeratosis (HP:0001036) | 2.61477974 |
| 50 | Hyperammonemia (HP:0001987) | 2.60500101 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 2.59050737 |
| 52 | Stomatitis (HP:0010280) | 2.58749466 |
| 53 | Coronal craniosynostosis (HP:0004440) | 2.58038108 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.58025431 |
| 55 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.58017117 |
| 56 | Epistaxis (HP:0000421) | 2.57893132 |
| 57 | Cardiovascular calcification (HP:0011915) | 2.57064907 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.55189291 |
| 59 | Hyperglycinemia (HP:0002154) | 2.52681765 |
| 60 | Premature skin wrinkling (HP:0100678) | 2.49972956 |
| 61 | T lymphocytopenia (HP:0005403) | 2.49260548 |
| 62 | Axonal loss (HP:0003447) | 2.48783284 |
| 63 | Hypercholesterolemia (HP:0003124) | 2.47143446 |
| 64 | Hyporeflexia of lower limbs (HP:0002600) | 2.47116338 |
| 65 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.47016657 |
| 66 | Meningitis (HP:0001287) | 2.45046432 |
| 67 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44026777 |
| 68 | Steatorrhea (HP:0002570) | 2.43991321 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.40893078 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39148832 |
| 71 | Obstructive lung disease (HP:0006536) | 2.39148832 |
| 72 | Obstructive sleep apnea (HP:0002870) | 2.37921056 |
| 73 | Ketosis (HP:0001946) | 2.36622708 |
| 74 | Insidious onset (HP:0003587) | 2.34303140 |
| 75 | Termporal pattern (HP:0011008) | 2.34303140 |
| 76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31904814 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31744994 |
| 78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31744994 |
| 79 | Hypophosphatemic rickets (HP:0004912) | 2.29997570 |
| 80 | Conjugated hyperbilirubinemia (HP:0002908) | 2.29382448 |
| 81 | Peripheral demyelination (HP:0011096) | 2.29156266 |
| 82 | Vasculitis (HP:0002633) | 2.27777837 |
| 83 | Onion bulb formation (HP:0003383) | 2.27123304 |
| 84 | Cellulitis (HP:0100658) | 2.25643246 |
| 85 | Chest pain (HP:0100749) | 2.24568179 |
| 86 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.22279406 |
| 87 | Aplasia of the phalanges of the hand (HP:0009802) | 2.22279406 |
| 88 | Aplasia involving bones of the extremities (HP:0009825) | 2.22279406 |
| 89 | Abnormality of binocular vision (HP:0011514) | 2.21709116 |
| 90 | Diplopia (HP:0000651) | 2.21709116 |
| 91 | Amyloidosis (HP:0011034) | 2.21439754 |
| 92 | Abnormality of T cell number (HP:0011839) | 2.21076580 |
| 93 | Pulmonary infiltrates (HP:0002113) | 2.21006457 |
| 94 | Arterial thrombosis (HP:0004420) | 2.20201448 |
| 95 | Abnormality of the intrinsic pathway (HP:0010989) | 2.19835269 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.19114848 |
| 97 | Keratoconjunctivitis (HP:0001096) | 2.18379858 |
| 98 | Increased IgE level (HP:0003212) | 2.16239008 |
| 99 | Hemoptysis (HP:0002105) | 2.16052691 |
| 100 | Slow saccadic eye movements (HP:0000514) | 2.15975301 |
| 101 | Hypoglycemic coma (HP:0001325) | 2.11703861 |
| 102 | Stridor (HP:0010307) | 2.11327573 |
| 103 | Encephalitis (HP:0002383) | 2.10964049 |
| 104 | Hemiplegia (HP:0002301) | 2.09981000 |
| 105 | Turricephaly (HP:0000262) | 2.09604829 |
| 106 | Back pain (HP:0003418) | 2.08163441 |
| 107 | Skin nodule (HP:0200036) | 2.07786009 |
| 108 | Protuberant abdomen (HP:0001538) | 2.07673282 |
| 109 | Postural instability (HP:0002172) | 2.07522940 |
| 110 | Intention tremor (HP:0002080) | 2.04970984 |
| 111 | Asymmetric septal hypertrophy (HP:0001670) | 2.04574355 |
| 112 | Bell-shaped thorax (HP:0001591) | 2.01696759 |
| 113 | Increased CSF protein (HP:0002922) | 2.00866011 |
| 114 | Increased cerebral lipofuscin (HP:0011813) | 2.00726456 |
| 115 | Inflammation of the large intestine (HP:0002037) | 2.00436512 |
| 116 | Exercise-induced myalgia (HP:0003738) | 2.00159044 |
| 117 | Peritonitis (HP:0002586) | 1.98768515 |
| 118 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.98609326 |
| 119 | Focal segmental glomerulosclerosis (HP:0000097) | 1.98231927 |
| 120 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97495299 |
| 121 | Purpura (HP:0000979) | 1.96733677 |
| 122 | Colitis (HP:0002583) | 1.96664573 |
| 123 | Spastic paraparesis (HP:0002313) | 1.96562369 |
| 124 | Esophageal varix (HP:0002040) | 1.95511754 |
| 125 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94779376 |
| 126 | Osteolytic defects of the hand bones (HP:0009699) | 1.94779376 |
| 127 | Muscle fiber inclusion bodies (HP:0100299) | 1.94582101 |
| 128 | Hyperglycinuria (HP:0003108) | 1.94179349 |
| 129 | Dysostosis multiplex (HP:0000943) | 1.93568323 |
| 130 | Sensory axonal neuropathy (HP:0003390) | 1.92738710 |
| 131 | Abnormal platelet volume (HP:0011876) | 1.90998968 |
| 132 | Abnormality of the fingertips (HP:0001211) | 1.90639983 |
| 133 | Abnormality of glycolipid metabolism (HP:0010969) | 1.90494418 |
| 134 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.90494418 |
| 135 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.90494418 |
| 136 | Vertigo (HP:0002321) | 1.90472760 |
| 137 | Hepatocellular carcinoma (HP:0001402) | 1.90413129 |
| 138 | Hematochezia (HP:0002573) | 1.90205093 |
| 139 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.90086824 |
| 140 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89711392 |
| 141 | Nemaline bodies (HP:0003798) | 1.88552176 |
| 142 | Gastrointestinal inflammation (HP:0004386) | 1.87394989 |
| 143 | Rickets (HP:0002748) | 1.87299754 |
| 144 | Prolonged neonatal jaundice (HP:0006579) | 1.85879657 |
| 145 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.85646216 |
| 146 | Disinhibition (HP:0000734) | 1.85328891 |
| 147 | Pulmonary embolism (HP:0002204) | 1.84612292 |
| 148 | Ileus (HP:0002595) | 1.84565119 |
| 149 | Abnormal auditory evoked potentials (HP:0006958) | 1.83803769 |
| 150 | Peripheral hypomyelination (HP:0007182) | 1.83757109 |
| 151 | Paraparesis (HP:0002385) | 1.83245613 |
| 152 | Supranuclear gaze palsy (HP:0000605) | 1.83200914 |
| 153 | Episodic fever (HP:0001954) | 1.82469755 |
| 154 | Frequent falls (HP:0002359) | 1.82312905 |
| 155 | Ventricular fibrillation (HP:0001663) | 1.82081777 |
| 156 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.82044922 |
| 157 | Cerebral hemorrhage (HP:0001342) | 1.81891162 |
| 158 | Sensorimotor neuropathy (HP:0007141) | 1.81569767 |
| 159 | Urticaria (HP:0001025) | 1.81193240 |
| 160 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.79399198 |
| 161 | Autoamputation (HP:0001218) | 1.78925980 |
| 162 | Polycythemia (HP:0001901) | 1.78665251 |
| 163 | Synostosis involving the elbow (HP:0003938) | 1.78386030 |
| 164 | Humeroradial synostosis (HP:0003041) | 1.78386030 |
| 165 | Abnormality of the ischium (HP:0003174) | 1.78144327 |
| 166 | Glomerulonephritis (HP:0000099) | 1.77991997 |
| 167 | Infantile muscular hypotonia (HP:0008947) | 1.76798141 |
| 168 | Mitral stenosis (HP:0001718) | 1.76776932 |
| 169 | Aortic aneurysm (HP:0004942) | 1.76771787 |
| 170 | Increased circulating renin level (HP:0000848) | 1.76526095 |
| 171 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75687833 |
| 172 | Subaortic stenosis (HP:0001682) | 1.75605703 |
| 173 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.75605703 |
| 174 | Hypoplastic ischia (HP:0003175) | 1.75009158 |
| 175 | Recurrent viral infections (HP:0004429) | 1.74969523 |
| 176 | Glomerulosclerosis (HP:0000096) | 1.74905348 |
| 177 | Subacute progressive viral hepatitis (HP:0006572) | 1.74231344 |
| 178 | Bifid scrotum (HP:0000048) | 1.73715065 |
| 179 | Ankle clonus (HP:0011448) | 1.73647070 |
| 180 | Metabolic alkalosis (HP:0200114) | 1.73088534 |
| 181 | Alopecia of scalp (HP:0002293) | 1.71854621 |
| 182 | Abnormality of the endocardium (HP:0004306) | 1.69909228 |
| 183 | Osteomyelitis (HP:0002754) | 1.69247253 |
| 184 | Thick nail (HP:0001805) | 1.69207755 |
| 185 | Abnormality of the peritoneum (HP:0002585) | 1.68825599 |
| 186 | Abnormality of the periventricular white matter (HP:0002518) | 1.68245107 |
| 187 | Scanning speech (HP:0002168) | 1.67617963 |
| 188 | Foot dorsiflexor weakness (HP:0009027) | 1.66139959 |
| 189 | Hypoplasia of the iris (HP:0007676) | 1.64411227 |
| 190 | Abnormality of the Achilles tendon (HP:0005109) | 1.63769535 |
| 191 | Abnormal gallbladder morphology (HP:0012437) | 1.63383817 |
| 192 | Pancreatitis (HP:0001733) | 1.63249201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.59452611 |
| 2 | EPHB1 | 4.23759326 |
| 3 | RIPK4 | 3.52937468 |
| 4 | PRPF4B | 2.92799819 |
| 5 | OXSR1 | 2.88554362 |
| 6 | MET | 2.69076665 |
| 7 | FGFR2 | 2.57347695 |
| 8 | BLK | 2.46602957 |
| 9 | SIK1 | 2.31822520 |
| 10 | MAP2K3 | 2.20405592 |
| 11 | PKN1 | 2.09484633 |
| 12 | FES | 2.05371531 |
| 13 | TYK2 | 1.99975375 |
| 14 | PBK | 1.95269777 |
| 15 | LATS1 | 1.91501441 |
| 16 | WNK4 | 1.80408388 |
| 17 | BCR | 1.79687152 |
| 18 | ERBB4 | 1.72883946 |
| 19 | ZAP70 | 1.68537555 |
| 20 | SGK2 | 1.67612211 |
| 21 | MAP4K1 | 1.62491667 |
| 22 | BCKDK | 1.56005346 |
| 23 | CSNK1A1L | 1.55998163 |
| 24 | SGK3 | 1.54365153 |
| 25 | KSR2 | 1.52440509 |
| 26 | EPHA2 | 1.50787317 |
| 27 | MAPKAPK5 | 1.49162281 |
| 28 | TXK | 1.47750922 |
| 29 | TTN | 1.46217075 |
| 30 | WNK1 | 1.43168576 |
| 31 | DDR2 | 1.42241132 |
| 32 | FGFR3 | 1.42174018 |
| 33 | IRAK4 | 1.41085954 |
| 34 | TNK2 | 1.37712739 |
| 35 | MAP3K1 | 1.33833716 |
| 36 | FGFR4 | 1.32322511 |
| 37 | SYK | 1.30570902 |
| 38 | MST1R | 1.29352551 |
| 39 | BTK | 1.28863678 |
| 40 | PTK2 | 1.28266581 |
| 41 | HCK | 1.27871168 |
| 42 | NEK6 | 1.26801215 |
| 43 | MAPK12 | 1.24495798 |
| 44 | PAK3 | 1.20226044 |
| 45 | MAPK15 | 1.18354300 |
| 46 | MAP3K7 | 1.18142254 |
| 47 | TAOK3 | 1.17468533 |
| 48 | OBSCN | 1.16879906 |
| 49 | BMX | 1.16183837 |
| 50 | SGK223 | 1.15459694 |
| 51 | SGK494 | 1.15459694 |
| 52 | CAMK1D | 1.15107883 |
| 53 | PTK6 | 1.14287993 |
| 54 | JAK3 | 1.14100886 |
| 55 | TYRO3 | 1.13795115 |
| 56 | PDGFRB | 1.12695103 |
| 57 | ERN1 | 1.12627439 |
| 58 | NEK9 | 1.10761627 |
| 59 | TRPM7 | 1.09644650 |
| 60 | CSNK1G3 | 1.07716395 |
| 61 | PRKD1 | 1.06721670 |
| 62 | CSNK1G1 | 1.06578888 |
| 63 | TESK2 | 1.06234704 |
| 64 | PDK1 | 1.04998136 |
| 65 | FGR | 1.04706393 |
| 66 | IKBKE | 1.04418143 |
| 67 | BMPR2 | 1.03743209 |
| 68 | TRIB3 | 1.03342622 |
| 69 | PIK3CA | 1.03316438 |
| 70 | ROCK2 | 1.03262452 |
| 71 | IRAK2 | 1.03214191 |
| 72 | GRK6 | 1.02422938 |
| 73 | NTRK3 | 1.01284509 |
| 74 | NLK | 0.99555287 |
| 75 | GSK3A | 0.99487912 |
| 76 | ICK | 0.98233698 |
| 77 | INSRR | 0.96886301 |
| 78 | CAMK1G | 0.96495180 |
| 79 | IRAK1 | 0.96047839 |
| 80 | PIK3CG | 0.95940698 |
| 81 | ITK | 0.94807852 |
| 82 | CAMKK1 | 0.94068867 |
| 83 | CAMKK2 | 0.92855588 |
| 84 | CSK | 0.92519795 |
| 85 | YES1 | 0.91575078 |
| 86 | STK3 | 0.91003810 |
| 87 | PDGFRA | 0.90821286 |
| 88 | EPHA3 | 0.89963748 |
| 89 | TEC | 0.87788813 |
| 90 | MAP3K11 | 0.87019377 |
| 91 | MST4 | 0.86679158 |
| 92 | PDPK1 | 0.86576917 |
| 93 | CAMK2D | 0.84150524 |
| 94 | CDC42BPA | 0.83605615 |
| 95 | FER | 0.83064750 |
| 96 | LYN | 0.81581824 |
| 97 | CSF1R | 0.81314494 |
| 98 | PRKCQ | 0.79805525 |
| 99 | CSNK1G2 | 0.79028424 |
| 100 | AKT3 | 0.78869350 |
| 101 | PHKG2 | 0.77206887 |
| 102 | PHKG1 | 0.77206887 |
| 103 | DAPK2 | 0.76336444 |
| 104 | RET | 0.76029561 |
| 105 | SGK1 | 0.75936396 |
| 106 | STK11 | 0.75177391 |
| 107 | PAK2 | 0.74313355 |
| 108 | LCK | 0.74043015 |
| 109 | TGFBR2 | 0.73099329 |
| 110 | JAK1 | 0.72407221 |
| 111 | LIMK1 | 0.71681100 |
| 112 | CAMK2B | 0.71484804 |
| 113 | CAMK2G | 0.69991275 |
| 114 | MAP3K6 | 0.69974634 |
| 115 | MAP3K2 | 0.69920524 |
| 116 | ABL2 | 0.69637170 |
| 117 | PTK2B | 0.69587478 |
| 118 | CAMK4 | 0.69362044 |
| 119 | MAP2K4 | 0.68632894 |
| 120 | KIT | 0.68544044 |
| 121 | ERBB2 | 0.65528349 |
| 122 | MAP2K2 | 0.64419452 |
| 123 | MAPK7 | 0.63500918 |
| 124 | PRKD3 | 0.63219191 |
| 125 | PRKAA2 | 0.62670571 |
| 126 | DYRK1B | 0.62659901 |
| 127 | PRKCE | 0.62205524 |
| 128 | STK38 | 0.62049526 |
| 129 | CDK19 | 0.61895618 |
| 130 | DMPK | 0.61787169 |
| 131 | NTRK1 | 0.61558240 |
| 132 | INSR | 0.60493759 |
| 133 | PRKCH | 0.60383471 |
| 134 | HIPK2 | 0.59178253 |
| 135 | MOS | 0.58926469 |
| 136 | STK38L | 0.58580442 |
| 137 | MARK3 | 0.56105913 |
| 138 | ABL1 | 0.54748258 |
| 139 | CAMK1 | 0.54637876 |
| 140 | MTOR | 0.53514945 |
| 141 | ROCK1 | 0.52747403 |
| 142 | PRKD2 | 0.52684525 |
| 143 | MAP3K3 | 0.52486907 |
| 144 | NUAK1 | 0.52243727 |
| 145 | TIE1 | 0.51910661 |
| 146 | RIPK1 | 0.51246569 |
| 147 | TAOK1 | 0.50405339 |
| 148 | FYN | 0.49995719 |
| 149 | UHMK1 | 0.48296764 |
| 150 | TBK1 | 0.47645179 |
| 151 | MAP3K13 | 0.47580509 |
| 152 | JAK2 | 0.46314681 |
| 153 | ACVR1B | 0.46223166 |
| 154 | MAP3K14 | 0.44644276 |
| 155 | PAK6 | 0.44641712 |
| 156 | FGFR1 | 0.44215719 |
| 157 | MARK2 | 0.41491803 |
| 158 | CDK6 | 0.40425296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.80771702 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.40052688 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.17687828 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.16907685 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.78257025 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.65444052 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.36681450 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.30763170 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.30654213 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22827168 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21470679 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16959760 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15950799 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07117618 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.07013802 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.05083633 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01059165 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.95756022 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88982823 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88841847 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87963040 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85691917 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81523461 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.76209038 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74806047 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74479074 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69892870 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.64201837 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55996758 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55660559 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.54959455 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52228273 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51353306 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50674159 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49437092 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48311103 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46059062 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44349687 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.36354622 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33892631 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.33119687 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32308589 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.30601324 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26576860 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26560158 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.26068636 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25665366 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23734705 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23436861 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22335405 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21926665 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.19578107 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19219501 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16743827 |
| 55 | Long-term potentiation_Homo sapiens_hsa04720 | 1.16487247 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13117983 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11868933 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11799749 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09992433 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.09241361 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08825505 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08363739 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08146226 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06954124 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04258175 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03841532 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.03497431 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03360506 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02973220 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.00987169 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99808737 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99045186 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98488041 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.96312924 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95744248 |
| 76 | Allograft rejection_Homo sapiens_hsa05330 | 0.95216545 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.94158103 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92909179 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92644680 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92617294 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92265698 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91626284 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.90886450 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90554737 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.89544806 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89542893 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87813869 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85954707 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85738358 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85362518 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85274786 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84622857 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.84160150 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.83817607 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.83758049 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83559965 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82779726 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82250317 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81591878 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.80164421 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79518483 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.78877945 |
| 103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78451043 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77766258 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77006923 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76995604 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76870325 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.75955377 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74610732 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74006649 |
| 111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73682798 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73544118 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72871400 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72812208 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72804697 |
| 116 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.69522620 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.69440807 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | 0.69067316 |
| 119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68754032 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68728608 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68649980 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67774420 |
| 123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67735691 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66595669 |
| 125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65403661 |
| 126 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64174953 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64114254 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63875200 |
| 129 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62952108 |
| 130 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61783848 |
| 131 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61411870 |
| 132 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61176155 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60331548 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60166925 |
| 135 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59968462 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58298359 |
| 137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58275702 |
| 138 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57992658 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57652162 |
| 140 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56094250 |
| 141 | Asthma_Homo sapiens_hsa05310 | 0.54145099 |
| 142 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53467594 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.50754834 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47686432 |
| 145 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47455666 |
| 146 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47077836 |
| 147 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46130995 |
| 148 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39387610 |
| 149 | Malaria_Homo sapiens_hsa05144 | 0.38572499 |
| 150 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36989246 |
| 151 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36605112 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35994278 |
| 153 | Axon guidance_Homo sapiens_hsa04360 | 0.35322114 |
| 154 | Mineral absorption_Homo sapiens_hsa04978 | 0.34955181 |
| 155 | Focal adhesion_Homo sapiens_hsa04510 | 0.34194426 |
| 156 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34063294 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33310658 |
| 158 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33104182 |
| 159 | Amoebiasis_Homo sapiens_hsa05146 | 0.31555683 |
| 160 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31267551 |
| 161 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30651549 |
| 162 | Insulin resistance_Homo sapiens_hsa04931 | 0.30574527 |
| 163 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29815915 |
| 164 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28044704 |
| 165 | Tight junction_Homo sapiens_hsa04530 | 0.26794593 |
| 166 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.24754431 |
| 167 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22834818 |
| 168 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.20142929 |
| 169 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19499146 |
| 170 | Phagosome_Homo sapiens_hsa04145 | 0.17870718 |
| 171 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16778732 |
| 172 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15837149 |
| 173 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15034571 |
| 174 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.14027081 |
| 175 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13932474 |
| 176 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13910592 |
| 177 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.12783519 |
| 178 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12685890 |
| 179 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.12284417 |
| 180 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.11717836 |
| 181 | Prostate cancer_Homo sapiens_hsa05215 | 0.09822111 |

